We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

In this section

Shares

Archive

No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.

Broker tips: AstraZeneca, Pan African Resources

Thu 13 February 2025 15:46

(Sharecast News) - UBS upgraded AstraZeneca from 'neutral' to 'buy' on Thursday, citing the pharmaceutical firm's "sector-leading" drug pipeline.

Berenberg slightly lowers target price on Pan African Resources

Thu 13 February 2025 12:36

(Sharecast News) - Analysts at Berenberg slightly lowered their target price on gold producer Pan African Resources from 42.0p to 39.0p on Thursday as they rebased their stance on the stock following the publication of its H1 numbers.

UBS ups rating on AstraZeneca to 'buy'

Thu 13 February 2025 11:18

(Sharecast News) - UBS has upgraded AstraZeneca to a 'buy', citing the London-listed pharmaceutical firm's "sector-leading" drug pipeline.

Broker tips: AstraZeneca, Smiths Group, Dunelm, S&U

Wed 12 February 2025 16:08

(Sharecast News) - Morgan Stanley has initiated coverage of pharma giant AstraZeneca with an 'overweight' rating and 14,5000p target price, recommending investors to build positions at a "compelling entry point".

Berenberg lowers target price on S&U

Wed 12 February 2025 11:11

(Sharecast News) - Analysts at Berenberg lowered their target price on finance business S&U from 2,100.0p to 1,700.0p on Wednesday but noted that the group was continuing to navigate a "challenging environment".

Canaccord Genuity hails growth prospects at Dunelm despite CEO exit

Wed 12 February 2025 11:00

(Sharecast News) - The surprise retirement of Dunelm's boss shouldn't put off investors from the homeware retailer's strong growth prospects, according to Canaccord Genuity which reiterated its 'buy' rating on the stock.

Morgan Stanley sees huge upside at AstraZeneca

Wed 12 February 2025 10:21

(Sharecast News) - Morgan Stanley has initiated coverage of pharma giant AstraZeneca with an 'overweight' rating, recommending investors to build positions at a "compelling entry point".

Citi lifts Smiths Group price target on break-up plans

Wed 12 February 2025 07:54

(Sharecast News) - Citi upped its price target on Smiths Group on Wednesday to 2,700p from 2,400p as it updated its break-up analysis.

Canaccord Genuity nudges up target price on Celtic

Tue 11 February 2025 16:47

(Sharecast News) - Analysts at Canaccord Genuity slightly raised their target price on Celtic from 202.0p to 208.0p on Tuesday, stating the firm's improved UCL campaign drives FY25 upgrades.

Broker tips: Entain, Celtic

Tue 11 February 2025 16:26

(Sharecast News) - Berenberg slightly raised its target price on bookmaker Entain from 1,010.0p to 1,035.0p on Tuesday, stating it was "continuing to bet" on the BetMGM turnaround.